artesunic acid has been researched along with Uveal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, J; Zheng, L | 1 |
Baur, A; Berger, TG; Dieckmann, D; Efferth, T; Funk, JO; Schuler, G; Schultz, ES | 1 |
2 other study(ies) available for artesunic acid and Uveal Neoplasms
Article | Year |
---|---|
The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
Topics: Adult; Analysis of Variance; Antimalarials; Antineoplastic Agents; Apoptosis; Artesunate; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Therapy, Combination; Glycogen Synthase Kinase 3 beta; Humans; Melanoma; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Uveal Neoplasms; Vincristine; Wnt Signaling Pathway | 2018 |
Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisia; Artemisinins; Artesunate; Dacarbazine; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Sesquiterpenes; Time Factors; Treatment Outcome; Uveal Neoplasms | 2005 |